GlaxoSmithKline Biologicals

Grantee website Rixensart, Antwerp, Belgium
Purpose
To characterize Klebsiella pneumoniae capsular (K) and sub-capsular (O) antigens among strains causing neonatal sepsis in low and middle-income countries
Division
Global Health
Date
OCTOBER 2021
Region served
GLOBAL
Committed amount
$519,894
Grant topic
Pneumonia
Duration (months)
23
Grantee location
Rixensart, Antwerp, Belgium

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.